2008, American Journal Of Pathology, 172, 1717, 10.2353/ajpath.2008.071054
Allin, 2012, British Journal of Cancer, 106, 199, 10.1038/bjc.2011.501
Bergmann, 2005, Clinical Cancer Research, 11, 8644, 10.1158/1078-0432.CCR-05-1317
2013, Endocrine-Related Cancer, 20, R83, 10.1530/ERC-12-0394
Brasso, 2006, The Prostate, 66, 503, 10.1002/pros.20311
Chandarlapaty, 2011, Cancer cell, 19, 58, 10.1016/j.ccr.2010.10.031
Chandran, 2007, BMC cancer [electronic resource], 7, 64, 10.1186/1471-2407-7-64
Chen, 2011, Clinical immunology (Orlando, Fla.), 140, 268, 10.1016/j.clim.2011.04.007
2013, BIOMARKERS IN MEDICINE, 7, 827, 10.2217/bmm.13.123
Culig, 2004, Current cancer drug targets, 4, 455, 10.2174/1568009043332925
Detchokul, 2011, British journal of clinical pharmacology, 71, 157, 10.1111/j.1365-2125.2010.03766.x
2013, Current oncology reports, 15, 239, 10.1007/s11912-013-0305-9
2011, Molecular Cancer Therapeutics, 10, 742, 10.1158/1535-7163.MCT-10-0868
2011, Journal of Biological Chemistry, 286, 15332, 10.1074/jbc.M110.212514
2010, American Journal Of Pathology, 176, 1959, 10.2353/ajpath.2010.090653
2011, CA: A Cancer Journal for Clinicians, 61, 69, 10.3322/caac.20107
Jensen, 2003, Clinical Cancer Research, 9, 4423
Jiang, 2004, Journal of experimental & clinical cancer research : CR, 23, 325
Johansen, 2006, Danish medical bulletin, 53, 172
Johansen, 2003, Breast cancer research and treatment, 80, 15, 10.1023/A:1024431000710
Johansen, 2006, Cancer Epidemiology Biomarkers & Prevention, 15, 194, 10.1158/1055-9965.EPI-05-0011
Johansen, 2007, Clinical Cancer Research, 13, 3244, 10.1158/1078-0432.CCR-06-2616
2009, FUTURE ONCOLOGY, 5, 1065, 10.2217/fon.09.66
2010, CELLULAR ONCOLOGY, 32, 11
Kawada, 2012, Oncogene, 31, 3111, 10.1038/onc.2011.498
Ku, 2011, International journal of cancer. Journal international du cancer, 128, 1316, 10.1002/ijc.25466
Kucur, 2008, Urologic oncology, 26, 47, 10.1016/j.urolonc.2007.07.020
Liao, 2003, Endocrinology, 144, 1656, 10.1210/en.2002-0157
Libreros, 2012, International journal of cancer. Journal international du cancer, 131, 377, 10.1002/ijc.26379
Ling, 2004, Biochemical Journal, 380, 651, 10.1042/BJ20040099
Livak, 2001, Methods (San Diego, Calif.), 25, 402, 10.1006/meth.2001.1262
Malinda, 1999, Experimental cell research, 250, 168, 10.1006/excr.1999.4511
Mulholland, 2011, Cancer cell, 19, 792, 10.1016/j.ccr.2011.05.006
2012, UROLOGY JOURNAL, 9, 568
Pagliarulo, 2012, European urology, 61, 11, 10.1016/j.eururo.2011.08.026
Recklies, 2002, Biochemical Journal, 365, 119, 10.1042/BJ20020075
2012, JOURNAL OF SIGNAL TRANSDUCTION, 2012, 169170
Shao, 2009, Oncogene, 28, 4456, 10.1038/onc.2009.292
Siegel, 2012, CA: A Cancer Journal for Clinicians, 62, 10, 10.3322/caac.20138
2011, Journal of Biological Chemistry, 286, 39893, 10.1074/jbc.M111.257451
2014, European urology, 65, 289, 10.1016/j.eururo.2013.08.008
Sun, 2009, The Prostate, 69, 1119, 10.1002/pros.20961
Sun, 2012, The Prostate, 72, 82, 10.1002/pros.21409
Thalmann, 1994, Cancer Research, 54, 2577
Thalmann, 2000, The Prostate, 44, 91, 10.1002/1097-0045(20000701)44:2<91::AID-PROS1>3.0.CO;2-L
2013, Molecular Cancer Therapeutics, 12, 2342, 10.1158/1535-7163.MCT-13-0032
Wang, 2007, Current cancer drug targets, 7, 591, 10.2174/156800907781662248
Yamac, 2008, Advances in therapy, 25, 801, 10.1007/s12325-008-0082-2
